BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
10.31
-0.11 (-1.06%)
Mar 9, 2026, 4:00 PM EDT - Market closed

BBOT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
373.6930.850.25
Short-Term Investments
51.77124.78-
Cash & Short-Term Investments
425.46155.630.25
Cash Growth
173.38%62152.40%-
Other Receivables
0.390.081.72
Receivables
0.390.081.72
Prepaid Expenses
6.552.981.96
Total Current Assets
432.4158.693.94
Property, Plant & Equipment
3.290.490.6
Other Long-Term Assets
12.75.121.41
Total Assets
448.38164.35.94
Accounts Payable
1.373.070.58
Accrued Expenses
32.6112.923.54
Current Portion of Leases
0.52--
Other Current Liabilities
0.533.5912.66
Total Current Liabilities
35.0419.5816.78
Long-Term Leases
2.24--
Total Liabilities
37.2919.5816.78
Common Stock
0.01--
Additional Paid-In Capital
767.6443.5432.61
Retained Earnings
-356.57-222.52-148.25
Comprehensive Income & Other
0.020.35-
Total Common Equity
411.1-178.64-115.64
Shareholders' Equity
411.1144.72-10.83
Total Liabilities & Equity
448.38164.35.94
Total Debt
2.77--
Net Cash (Debt)
422.69155.630.25
Net Cash Growth
171.60%62152.40%-
Net Cash Per Share
13.5712061.612.00
Filing Date Shares Outstanding
80.030.320.12
Total Common Shares Outstanding
79.990.320.12
Working Capital
397.36139.11-12.84
Book Value Per Share
5.14-558.92-927.16
Tangible Book Value
411.1-178.64-115.64
Tangible Book Value Per Share
5.14-558.92-927.16
Source: S&P Capital IQ. Standard template. Financial Sources.